Repurposing of drug candidates against Epstein–Barr virus: Virtual screening, docking computations, molecular dynamics, and quantum mechanical study
PLOS ONE · 15.11.2024 · 19 (11) · e0312100
DOI: 10.1371/journal.pone.0312100 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 15.11.2024. Verfasst von Mahmoud A A Ibrahim und 9 weiteren Autor:innen. Beteiligte Einrichtung: Computational Chemistry Laboratory, Chemistry Department, Faculty of Science, Minia University, Minia, Egypt. Hauptthemen laut MEDLINE: Herpesvirus 4, Human, Molecular Dynamics Simulation, Molecular Docking Simulation, Drug Repositioning. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Epstein–Barr virus (EBV) was the first tumor virus identified in humans, and it is mostly linked to lymphomas and cancers of epithelial cells. Nevertheless, there is no FDA-licensed drug feasible for this ubiquitous EBV viral contagion. EBNA1 (Epstein-Barr nuclear antigen 1) plays several roles in the replication and transcriptional of latent gene expression of the EBV, making it an attractive druggable target for the treatment of EBV-related malignancies. The present study targets EBV viral reactivation and upkeep by inhibiting EBNA1 utilizing a drug-repurposing strategy. To hunt novel EBNA1 inhibitors, a SuperDRUG2 database (> 4,600 pharmaceutical ingredients) was virtually screened utilizing docking computations. In accordance with the estimated docking scores, the most promising drug candidates then underwent MDS (molecular dynamics simulations). Besides, the MM-GBSA approach was applied to estimate the binding affinities between the identified drug candidates and EBNA1. On the basis of MM-GBSA//200 ns MDS, bezitramide (SD000308), glyburide (SD001170), glisentide (SD001159), and glimepiride (SD001156) unveiled greater binding affinities towards EBNA1 compared to KWG, a reference inhibitor, with Δ G binding values of −44.3, −44.0, −41.7, −40.2, and −32.4 kcal/mol, respectively. Per-residue decomposition analysis demonstrated that LYS477, ASN519, and LYS586 significantly interacted with the identified drug candidates within the EBNA1 binding pocket. Post-dynamic analyses also demonstrated high constancy of the identified drug candidates in complex with EBNA1 throughout 200 ns MDS. Ultimately, electrostatic potential and frontier molecular orbitals analyses were performed to estimate the chemical reactivity of the identified EBNA1 inhibitors. Considering the current outcomes, this study would be an adequate linchpin for forthcoming research associated with the inhibition of EBNA1; however, experimental assays are required to inspect the efficiency of these candidates.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Computational Chemistry Laboratory, Chemistry Department, Faculty of Science, Minia University, Minia, Egypt.
- School of Health Sciences, University of KwaZulu-Natal, Westville Campus, Durban, South Africa.
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Tanta University, Tanta, Egypt.
- Department of Botany and Microbiology, College of Science, King Saud University, Riyadh, Saudi Arabia.
- Centre for Pharmaceutical Engineering Science, Faculty of Life Science, School of Pharmacy and Medical Sciences, University of Bradford, Bradford, United Kingdom.
- Department of Chemistry, The American University in Cairo, New Cairo, Egypt.
ORCID-Profile: Mahmoud A A Ibrahim, Eslam A R Mohamed, Mohamed A El-Tayeb, Shahzeb Khan, Mahmoud E S Soliman
Zitieren
APA
Ibrahim, M. A. A., Hassan, A. M. A., Mohamed, E. A. R., Mekhemer, G. A. H., Sidhom, P. A., El-Tayeb, M. A., Khan, S., Shoeib, T., Soliman, M. E. S., & Abdelrahman, A. H. M. (2024). Repurposing of drug candidates against Epstein–Barr virus: Virtual screening, docking computations, molecular dynamics, and quantum mechanical study. PLOS ONE, 19(11), e0312100. https://doi.org/10.1371/journal.pone.0312100
Vancouver
Ibrahim MAA, Hassan AMA, Mohamed EAR, Mekhemer GAH, Sidhom PA, El-Tayeb MA, et al. Repurposing of drug candidates against Epstein–Barr virus: Virtual screening, docking computations, molecular dynamics, and quantum mechanical study. PLOS ONE. 2024;19(11):e0312100. doi:10.1371/journal.pone.0312100
BibTeX
@article{Ibrahim2024,
author = {Ibrahim, Mahmoud A A and Hassan, Alaa M A and Mohamed, Eslam A R and Mekhemer, Gamal A H and Sidhom, Peter A and El-Tayeb, Mohamed A and Khan, Shahzeb and Shoeib, Tamer and Soliman, Mahmoud E S and Abdelrahman, Alaa H M},
title = {Repurposing of drug candidates against Epstein–Barr virus: Virtual screening, docking computations, molecular dynamics, and quantum mechanical study},
journal = {PLOS ONE},
year = {2024},
volume = {19},
number = {11},
pages = {e0312100},
doi = {10.1371/journal.pone.0312100}
}
EUVIMED